title: Diagnosis and treatment of cytomegalovirus iridocyclitis without retinal necrosis.
abstract: OBJECTIVE
  To describe the diagnostic and therapeutic management of cytomegalovirus (CMV) anterior uveitis unassociated with retinal necrosis in immunocompetent patients.
  
  
  METHODS
  Patients referred between 2001 and 2003 for management of unilateral, chronic, recurrent uveitis associated with secondary glaucoma underwent extensive investigation including laboratory tests for herpes virus infections. Specific antiviral treatment was initiated in all cases and the level of ocular inflammation was evaluated during the follow up.
  
  
  RESULTS
  Five patients, three men and two women, were included. Median age was 50 years old (range 30-80 years). Anterior unilateral uveitis without iris atrophy was observed in all cases. Uveitis was chronic in three cases and recurrent in two cases. Glaucoma was observed in all patients with a median intraocular pressure of 30 mm Hg (range 22-43 mm Hg). Five patients responded initially to specific anti-CMV therapy. Even though glaucoma surgery was necessary in two cases, both ocular inflammation and glaucoma were controlled in all cases. Relapses occurred in three cases after cessation of therapy, requiring prolonged maintenance therapy with valganciclovir.
  
  
  CONCLUSIONS
  CMV infection and specific antiviral therapy should be considered in all cases of relapsing or chronic iridocyclitis and secondary glaucoma. Maintenance regimens of valganciclovir may be necessary to prevent further relapses.
authors.affiliation: Department of Ophthalmology, University of Paris VI, Pitié-Salpêtrière Hospital, 47-83 bd de l'Hôpital, 75651 Paris, France.
authors.forename: I
authors.initials: I
authors.lastname: de Schryver
authors.forename: F
authors.initials: F
authors.lastname: Rozenberg
authors.forename: N
authors.initials: N
authors.lastname: Cassoux
authors.forename: S
authors.initials: S
authors.lastname: Michelson
authors.forename: P
authors.initials: P
authors.lastname: Kestelyn
authors.forename: P
authors.initials: P
authors.lastname: Lehoang
authors.forename: J L
authors.initials: JL
authors.lastname: Davis
authors.forename: B
authors.initials: B
authors.lastname: Bodaghi
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000998:Antiviral Agents / Q000627:therapeutic use; D002908:Chronic Disease; D003587:Cytomegalovirus / Q000235:genetics; D003586:Cytomegalovirus Infections / Q000175:diagnosis* / Q000188:drug therapy; D004279:DNA, Viral / Q000032:analysis; D015828:Eye Infections, Viral / Q000175:diagnosis* / Q000188:drug therapy; D005260:Female; D005500:Follow-Up Studies; D017245:Foscarnet / Q000627:therapeutic use; D015774:Ganciclovir / Q000031:analogs & derivatives / Q000627:therapeutic use; D005902:Glaucoma, Open-Angle / Q000821:virology; D006068:Gonioscopy; D006801:Humans; D015863:Iridocyclitis / Q000188:drug therapy / Q000821:virology*; D008297:Male; D008875:Middle Aged; D012008:Recurrence; D012189:Retrospective Studies; D014606:Uveitis, Anterior / Q000188:drug therapy / Q000821:virology; D000077562:Valganciclovir; D014822:Vitreous Body / Q000821:virology
chemical_list: D000998:Antiviral Agents; D004279:DNA, Viral; D017245:Foscarnet; D000077562:Valganciclovir; D015774:Ganciclovir